BCG immunotherapy for superficial bladder cancer.
Lane
T
T
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage*; D006801:Humans; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine